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Immunohistochemical staining indi-
cated that MBTPS2 is mainly expressed
in the upper granular layer in normal
skin, as previously shown (Aten et al.,
2010); however, in OS skin, MBTPS2
was expressed throughout the epi-
dermis (Figure 2c). There was no
apparent difference in MBTPS2 locali-
zation in the skin of a KFSD patient with
the p.N508S mutation (Aten et al.,
2010). It is unclear why this is but it
may be because of differences in
processing of the mutants in the two
diseases.
In summary, we demonstrate a novel
association between an MBTPS2 muta-
tion and an X-linked form of OS. This
expands the number of disorders linked
to MBTPS2 mutations and reveals clin-
ical heterogeneity associated with dif-
ferent MBTPS2 mutations.
Written, informed consent was
obtained from all family members or
their legal guardians. This study was
approved by the South East NHS
Research Ethics Committee and was
performed according to the Declaration
of Helsinki Principles.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We thank Barts and The London Charity for its
financial support (to DPK).
Alireza Haghighi1,6, Claire A. Scott2,6,
Daniel S. Poon2, Reza Yaghoobi3,
Nasrollah Saleh-Gohari4,
Vincent Plagnol5 and David P. Kelsell2
1The Wellcome Trust Center for Human
Genetics, Nuffield Department of Clinical
Medicine, University of Oxford, Oxford, UK;
2Centre for Cutaneous Research, The Blizard
Institute, Barts & The London School of
Medicine and Dentistry, Queen Mary
University of London, London, UK;
3Department of Dermatology, Jundishapur
University of Medical Sciences, Ahvaz, Iran;
4Genetic Department, Kerman University of
Medical Sciences, Kerman, Iran and 5Darwin
Building, University College London Genetics
Institute, University College London, London,
UK
E-mail: d.p.kelsell@qmul.ac.uk
6These authors contributed equally to this work
and should be considered joint first author.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online
version of the paper at http://www.nature.com/jid
REFERENCES
Aten E, Brasz LC, Bornholdt D et al. (2010)
Keratosis follicularis spinulosa decalvans is
caused by mutations in MBTPS2. Hum Mut
31:1125–33
Bergonse FN, Rabello SM, Barreto RL et al. (2003)
Olmsted syndrome: the clinical spectrum of
mutilating palmoplantar keratoderma. Pediatr
Dermatol 20:323–6
Cambiaghi S, Tadini G, Barbareschi M et al.
(1995) Olmsted syndrome in twins. Arch
Dermatol 131:738–9
Ding YG, Wang JY, Qiao JJ et al. (2010) A novel
mutation in MBTPS2 causes ichthyosis folli-
cularis, alopecia and photophobia (IFAP)
syndrome in a Chinese family. Br J Dermatol
163:886–9
Larregue M, Callot V, Kanitakis J et al. (2000)
Olmsted syndrome: report of two new cases
and literature review. J Dermatol 27:557–68
Lin Z, Chen Q, Lee M et al. (2012) Exome
sequencing reveals mutations in TRPV3 as a
cause of Olmsted syndrome. Am J Hum
Genet 90:558–64
Mevorah B, Goldberg I, Sprecher E et al. (2005)
Olmsted syndrome: mutilating palmo-
plantar keratoderma with periorificial
keratotic plaques. J Am Acad Dermatol 53:
S266–72
Naiki M, Mizuno S, Yamada K et al. (2012)
MBTPS2 mutation causes BRESEK/BRESHECK
syndrome. Am J Med Genet A 158A:97–102
Oeffner F, Fischer G, Happle R et al. (2009) IFAP
syndrome is caused by deficiency in MBTPS2,
an intramembrane zinc metalloprotease essen-
tial for cholesterol homeostasis and ER stress
response. Am J Hum Genet 84:459–67
Olmsted HC (1927) Keratodermia palmaris et
plantaris congenitalis. Am J Dis Child
33:757–64
Sakai J, Nohturfft A, Goldstein JL et al. (1998)
Cleavage of sterol regulatory element-
binding proteins (SREBPs) at site-1 requires
interaction with SREBP cleavage-activating
protein. Evidence from in vivo competition
studies. J Biol Chem 273:5785–93
Tang L, Liang J, Wang W et al. (2011) A novel
mutation in MBTPS2 causes a broad pheno-
typic spectrum of ichthyosis follicularis,
atrichia, and photophobia syndrome in a
large Chinese family. J Am Acad Dermatol
64:716–22
Tang L, Zhang L, Ding H et al. (2012) Olmsted
syndrome: a new case complicated with
easily broken hair and treated with oral
retinoid. J Dermatol 39:1–2
Yaghoobi R, Omidian M, Sina N et al. (2007)
Olmsted syndrome in an Iranian family: report
of two new cases. Arch Iran Med 10:246–9
Ye J, Rawson RB, Komuro R et al. (2000) ER stress
induces cleavage of membrane-bound ATF6
by the same proteases that process SREBPs.
Mol Cell 6:1355–64
Zelenski NG, Rawson RB, Brown MS et al.
(1999) Membrane topology of S2P, a
protein required for intramembranous
cleavage of sterol regulatory element-bind-
ing proteins. J Biol Chem 274:21973–80
Targeted Sequence Capture and High-Throughput
Sequencing in the Molecular Diagnosis of Ichthyosis
and Other Skin Diseases
Journal of Investigative Dermatology (2013) 133, 573–576; doi:10.1038/jid.2012.332; published online 20 September 2012
TO THE EDITOR
The inherited ichthyoses are a large and
genetically heterogeneous group of
Mendelian disorders of cornification,
characterized by scaling and/or hyper-
keratosis over the majority of the
integument (Oji et al., 2010). The two
main nonsyndromic ichthyosis groups
are autosomal recessive congenital
ichthyosis (ARCI), encompassing lamel-
lar ichthyosis (LI), congenital ichthyosi-
form erythroderma (CIE), and harlequin
ichthyosis (HI), in which patients are
Abbreviations: ARCI, autosomal recessive congenital ichthyosis; CIE, congenital ichthyosiform
erythroderma; HI, harlequin ichthyosis; KPI, keratinopathic ichthyosis; LI, lamellar ichthyosis; NGS, next-
generation sequencing; SPPK, striate palmoplantar keratoderma; SNP, single-nucleotide polymorphism
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usually born as collodion babies; and
keratinopathic ichthyoses (KPI), the two
main groups of which are epidermolytic
ichthyosis (EI) and superficial epider-
molytic ichthyosis (SEI) (Oji et al.,
2010). KPI are linked to mutations in
keratin genes. Mutations in ABCA12 are
associated with HI, the most deva-
stating and frequently lethal form of
ichthyosis (Akiyama et al., 2005; Kelsell
et al., 2005). However, mutations in
multiple genes (Table 1), including
ABCA12, are linked to LI and CIE,
which display clinical overlap (Akiya-
ma et al., 2003).
As mutations in multiple genes are
linked to nonsyndromic and syndromic
ichthyosis, undertaking genetic screen-
ing by PCR and Sanger sequencing in a
gene-by-gene approach is labor-inten-
sive and expensive. Screening known
ichthyosis genes simultaneously in a
patient (or multiple patients) could en-
able a swifter identification of gene
mutations in patients and facilitate pre-
natal diagnosis and genetic counseling.
Next-generation sequencing (NGS)
has proven effective in the discovery of
mutations in novel disease-associated
genes, for example, by exome sequen-
cing (Ng et al., 2009) or by targeted
sequence capture of chromosomal re-
gions previously linked to a condition
(Blaydon et al., 2011, 2012). For con-
ditions associated with mutations in
multiple known genes, targeted gene
capture coupled with NGS has shown
promise in the molecular diagnosis of
disease (Berg et al., 2011; Artuso et al.,
2012). Here, we designed a custom
NimbleGen microarray for sequence
capture and NGS of the ABCA12 gene
locus, as well as the exons of 23 other
genes linked to nonsyndromic and
syndromic forms of ichthyosis, acral
peeling skin syndrome/peeling (APSS)
skin syndrome (PSS) or striate palmoplan-
tar keratoderma (SPPK; Table 1), on
pooled DNA consisting of 14 genomic
DNA samples (Supplementary Informa-
tion and Supplementary Table S1 online).
We discovered 12 sequence var-
iants, which, to our knowledge, have
not been reported previously (three
deletions leading to frameshifts, seven
missense, one nonsense, and one splice
site), and four known disease-asso-
ciated mutations (Table 2). The hetero-
zygous whole-exon 8 deletion
previously discovered by multiplex
and oligonucleotide array analysis
(Thomas et al., 2006) in Sample 11
was not detected, indicating that cur-
rently NGS may not be sensitive en-
ough to detect all complex or large
insertion/deletion mutations. However,
a predicted intronic splice site mutation
was found, and this is likely to be the
second disease-causing mutation in Sam-
ple 11. In contrast, a homozygous large
101bp deletion (p.I1128EfsX38) within
exon 24 of ABCA12 was detected by this
capture method. Known whole-exon
deletions have been undetectable in
other sequence capture investigations
(Berg et al., 2011). Other non-microarray
Table 1. Genes implicated in ichthyosis and other skin diseases on the
custom capture microarray
Gene OMIM
Cytogenetic
location (hg19)
Disease(s) with
skin phenotype
Exons captured
ABHD5 *604780 3p21.33 CDS
AP1S1 *603531 7q22.1 MEDNIK
ALOXE3 *607206 17p13.1 ARCI (CIE)
ALOX12B *603741 17p13.1 ARCI (CIE)
CDSN *602593 6p21.33 Hypotrichosis, PSS
CSTA *184600 3q21.1 AREI
CYP4F22 *611495 19p13.12 ARCI (LI)
DSG1 *125670 18q12.1 SPPK1
DSP *125647 6p24.3 DCWHK, LAEB, SFWHS, SPPK2
GJB2 *121011 13q12.11 BPS, HID, KID, PPK with deafness
GJB3 +603324 1p34.3 EKV
GJB4 *605425 1p34.3 EKV
KRT1 *139350 12q13.13 AEI, EI, EPPK, ICM, NEPPK, SPPK3
KRT2 *600194 12q13.13 SEI
LOR *152445 1q21.3 LK
NIPAL4 *609383 5q33.3 ARCI (CIE)
POMP *613386 13q12.3 KLICK
SLC27A4 *604194 9q34.11 IPS
SLURP1 *606119 8q24.3 MDM
SPINK5 *605010 5q32 Atopy, NS
STS #308100 Xp22.31 XLI
TGM1 *190195 14q12 ARCI (CIE, LI)
TGM5 *603805 15q15.2 APSS
Exons, introns
ABCA12 *607800 2q35 ARCI (CIE, LI, HI)
Abbreviations: AEI, annular epidermolytic ichthyosis; APSS, acral peeling skin syndrome; ARCI,
autosomal recessive congenital ichthyosis; AREI, autosomal recessive exfoliative ichthyosis; BPS, Bart-
Pumphrey syndrome; CDS, Chanarin-Dorfman syndrome; CIE, congenital ichthyosiform erythroder-
ma; DCWHK, dilated cardiomyopathy with woolly hair and keratoderma; EI, epidermolytic ichthyosis;
EKV, erythrokeratoderma variabilis; EPPK, epidermolytic palmoplantar keratoderma; HI, harlequin
ichthyosis; HID, hystrix-like ichthyosis with deafness; ICM, ichthyosis histrix, Curth-Macklin type; IPS,
ichthyosis prematurity syndrome; KID, keratitis–ichthyosis–deafness syndrome; KLICK, keratosis
linearis–ichthyosis congenital–keratoderma; LAEB, lethal acantholytic epidermolysis bullosa; LI,
lamellar ichthyosis; LK, loricrin keratoderma; MDM, mal de Meleda; MEDNIK, mental retardation,
enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratodermia; NEPPK, nonepidermo-
lytic palmoplantar keratoderma; NS, Netherton syndrome; PPK, palmoplantar keratoderma; PSS,
peeling skin syndrome; SEI, superficial epidermolytic ichthyosis; SFWHS, skin fragility–woolly hair
syndrome; SPPK, striate palmoplantar keratoderma; XLI, X-linked recessive ichthyosis.
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based NGS platforms with individual
patient DNA bar coding are now avail-
able, which may show more efficacy in
large insertion/deletion detection.
ABCA12 mutations were found in all
HI patients on the microarray, includ-
ing in Samples 10 (Rajpopat et al.,
2011) and 11 (Kelsell et al., 2005) from
previous studies, and Sample 14 (an
unaffected mother of an HI patient) in
whom ABCA12mutations had not been
identified using PCR and Sanger se-
quencing methods described previously
(Lefevre et al., 2003).
Before this study, we extracted RNA
from the skin of Sample 14 and, using
the ABCA12 single nucleotide poly-
morphism (SNP) rs10498030 found in
the genomic DNA of Sample 14 as a
marker, confirmed by reverse trans-
cription–PCR and Sanger sequencing
Table 2. Mutations found in this study using custom sequence capture and NGS
Disease Sample ID Gender
Gene/NCBI
nucleotide ID Exon
Mutation discovered
in this study
Mutation
type Reference/comment
ARCI (CIE/LI) 1 F ALOX12B
(NM_001139.2)
2 c.266T4C (p.I89T)1 MS This study
2 F — — — — —
3 M CYP4F22
(NM_173483.3)
6 c.712G4A
(p.A238T)2
MS This study
4 F ABCA12
(NM_173076.2)
28 c.4070C4A
(p.S1357X)2
MS This study
28 c.4139A4G (p.N1380S)2 MS Lefevre et al. (2003)
(HGMD no. CM032165)
5 M — — — — —
6 M — — — — —
SPPK 7 F DSG1
(NM_001942.2)
4 c.277delG
(p.D93IfsX19)2
FS This study
APSS 8 F — — — — —
ARCI (HI) atypical,
chrysalis
9 M ABCA12
(NM_173076.2)
40 c.5936C4G
(p.A1979G)2
MS This study
46 c.6858delT
(p.F2286LfsX6)2
FS This study
ARCI (HI) 10 F ABCA12
(NM_173076.2)
24 c.3381_3481del
(p.I1128EfsX38)1
FS This study
11 F ABCA12
(NM_173076.2)
— c.2332+2T4G2
(intron 17)
SS This study. Known to
be heterozygous
for a whole-exon 8 deletion
(Thomas et al., 2006)
12 F ABCA12
(NM_173076.2)
2 c.130C4G (p.R44G)2 MS This study
16 c.2033A4G (p.N678S)2 MS rs147218173
TGM1
(NM_000359.2)
2 c.401A4G (p.Y134C)2 MS Farasat et al. (2009),
rs147916609
13 F ABCA12
(NM_173076.2)
3 c.179G4G (p.R60P)2 MS This study
12 c.1300C4T (p.R434X)2 NS Akiyama et al. (2005),
(HGMD no. CM052164)
Unaffected mother
of a HI baby
14 F ABCA12
(NM_173076.2)
12 c.1446A4C (p.E482D)2 MS This study
51 c.7444C4T (p.R2482X)2 NS Akiyama et al. (2007),
(HGMD no. CM073950)
NIPAL4
(NM_001099287.1)
1 c.197G4A (p.R66Q)2 MS This study
Abbreviations: APSS, acral peeling skin syndrome; ARCI, autosomal recessive congenital ichthyosis; CIE, congenital ichthyosiform erythroderma;
F, female; FS, frameshift; HI, harlequin ichthyosis; LI, lamellar ichthyosis; M, male; MS, missense; NS, nonsense; SPPK, striate palmoplantar keratoderma;
SS, splice site.
1Homozygous.
2Heterozygous.
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that only one allele of ABCA12 was
expressed. This suggested the presence
of a regulatory ABCA12 gene mutation.
However, NGS and confirmation by a
restriction digest revealed the presence
of p.R2482X in exon 51 in Sample 14.
PCR and Sanger sequencing with rede-
signed exon 51 primers confirmed this
mutation and indicated that biased
amplification of the wild-type allele
had occurred during the previous PCR
amplification of exon 51 (due to Sam-
ple 14 being heterozygous for SNP
rs3738884 in the original exon 51
reverse primer sequence), resulting in
the mutation being missed.
Homozygous or compound heterozy-
gous ABCA12 deletion or truncation
mutations usually lead to HI, whereas
missense mutations cause LI or more
rarely CIE (reviewed in Akiyama, 2006).
Screening multiple genes simultaneously
in patients allows variants in multiple
genes to be identified and thus potential
phenotype–genotype correlations to be
established. For example, in this study,
Sample 12, an adult patient with a milder
HI phenotype, harbored two missense
changes in ABCA12, as well as the
missense TGM1 mutation p.Y134C,
which has been previously linked to CIE
(Farasat et al., 2009). Potentially, the inter-
action of these three missense changes in
two genes linked to ichthyosis could be
detrimental enough to cause HI, but with
a less severe phenotype than normal.
A heterozygous DSG1 mutation
p.D93IfsX19 was found in SPPK patient
Sample 7, which indicates that the patient
has SPPK1. Disease-causing mutations
were not identified in Samples 2, 5, 6,
or 8. Mutations in genes not present on
the microarray, or complex mutations in
known ichthyosis genes that were not
detected by NGS, could form the genetic
basis of disease in the other patients.
In summary, our study expands the
numbers of mutations associated with
ARCI and SPPK1 and demonstrates that
sequence capture coupled with NGS can
be used successfully as an accurate and
cost-effective tool in the molecular diag-
nosis of ichthyosis and other skin dis-
eases. Where no disease-causing muta-
tion is identified in a targeted sequence
capture approach, whole-exome/genome
sequencing could be undertaken to iden-
tify novel loci associated with disease.
DNA pooling and sequence capture
on a single microarray was feasible in
this study because of the small number
of patient samples. However, other
technologies are becoming available
that allow for sequence enrichment for
candidate genes without library pre-
paration plus indexing samples both for
candidate genes and whole exome
before NGS. The power of this technol-
ogy has already had an impact on new
disease gene discovery and diagnostics,
and the continuing marked reductions
in cost to run these genetic technologies
will allow molecular diagnosis as a
standard investigation in patient diag-
nosis and clinical management.
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